HLNCF

Haleon plc

OTC · Perfumes, Cosmetics & Other Toilet Preparations · Inc. X0 · CIK 0001900304
$4.46 +3.72%
Vol
SEC Reports13

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

13 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 13 neutral. Avg impact: 2.5/10.
NEUTRAL 6-K 3/10
Haleon plc filed a Form 6-K reporting the purchase of 16,585,448 ordinary shares for cancellation un
Jun 8, 2026
NEUTRAL 6-K 2/10
Haleon filed a routine Form 6-K disclosing its total voting rights and capital as of May 31, 2026. T
Jun 1, 2026
NEUTRAL 6-K 2/10
Haleon plc disclosed the purchase of 10,149,493 ordinary shares for cancellation under its existing
Jun 1, 2026
NEUTRAL 6-K 2/10
Haleon plc disclosed the purchase of 2,458,291 ordinary shares for cancellation under its existing b
May 26, 2026
NEUTRAL 6-K 2/10
Haleon plc filed a Form 6-K disclosing the purchase of 10,205,329 ordinary shares for cancellation u
May 11, 2026
NEUTRAL 6-K 2/10
Haleon plc published updated listing particulars for its £10 billion Euro Medium Term Note (EMTN) Pr
May 7, 2026
NEUTRAL 6-K 2/10
Haleon plc disclosed the repurchase of 12,171,987 ordinary shares for cancellation under its existin
May 5, 2026
NEUTRAL 6-K 2/10
Haleon filed a routine monthly update of total voting rights and capital, disclosing 8,891,932,595 i
May 1, 2026
NEUTRAL 6-K 2/10
Haleon plc reported the results of its 2026 Annual General Meeting, where all 23 resolutions were pa
Apr 29, 2026
NEUTRAL 6-K 4/10
Haleon plc announced the purchase of 7,740,513 ordinary shares for cancellation under its share buyb
Apr 13, 2026
NEUTRAL 6-K 3/10
Haleon plc announced the purchase of 5,266,782 ordinary shares for cancellation under its share buyb
Apr 7, 2026
NEUTRAL 6-K 2/10
Haleon plc filed a routine 6-K disclosing its total voting rights and capital structure as of March
Apr 1, 2026
NEUTRAL 6-K 4/10
Haleon plc announced the purchase of 8,939,706 ordinary shares for cancellation under its share buyb
Mar 30, 2026

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 77% buy across 26 analysts — 7 strong buy, 13 buy, 4 hold, 2 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-03-31
$0.00 $0.00 $0.00 $2.9B 0.6%
Next Q
2026-06-30
$0.00 $0.00 $0.00 $2.7B 4.0%
Current FY
2026-12-31
$0.00 $0.00 $0.00 $11.4B 3.2%
Next FY
2027-12-31
$0.00 $0.00 $0.00 $11.9B 4.3%

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202671342077%
May 1, 202671342077%
Apr 1, 202671332080%
Mar 1, 202671332080%
Feb 1, 202671332080%
Jan 1, 202671061071%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 27, 2026
FDA
Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distributed by: Haleon, Warren, NJ 07059, UPC: 3 00674 35041 9.
Class II: Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.